• Markets
    • icon
  • Companies
HCW · ASX

HealthCo Healthcare & Wellness REIT (ASX:HCW)

AU$1.37

 0.0 (0.0%)
ASX:Live
01/12/2023 04:10:47 PM
HALO Small HALO Ords GROWTH AUS All-Consensus All-Companies
Consensus Score
/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

HCW Overview

HCW Health Scores

Short Term

Mean Revision

Trend

Event

Halo Model

MQV

GARP

MQV Small

Valuation

Value

Consensus

Momentum

Price

Earnings

Growth

Earnings

Dividends

Quality

Capital Efficiency

Balance Sheet

About HCW

Website

N/A

Telephone

N/A

Address

1 Macquarie Place Sydney, New South Wales (NSW) 2000

Description

HealthCo Healthcare & Wellness REIT operates as a real estate investment trust. It invests in various portfolios including hospitals, aged care, childcare, government, life sciences & research and primary care & wellness property assets, as well as other healthcare and wellness property adjacencies. The company is headquartered in Sydney, Australia.

HCW Price Chart

Key Stats

Market Cap

AU$752.96M

PE

21.80

EV/EBITDA

37.5

Dividends Overview

DIV Yield

5.7%

Franking

N/A

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 1.27 - 1.8

Trade Value (12mth)

AU$458,104.00

1 week

-4.2%

1 month

-2.14%

YTD

-18.83%

1 year

-15.64%

All time high

2.35507

Key Fundamentals

EPS 3 yr Growth

N/A

EBITDA Margin

106.90%

Operating Cashflow

$11m

Free Cash Flow Return

1.00%

ROIC

1.70%

Interest Coverage

4.10

Quick Ratio

0.00

Other Data

Shares on Issue (Fully Dilluted)

376m

HALO Sector

Real Estate

Next Company Report Date

08-Aug-24

Ex Dividend Date (est.)

N/A

Next Dividend Pay Date (est.)

N/A

Reporting Currency

AUD

Short Sell (% of issue)

3.10

HCW Announcements

Latest Announcements

Date Announcements

31 March 23

Successful Completion of Placement & Inst. Entitlement Offer

×

Successful Completion of Placement & Inst. Entitlement Offer

31 March 22

Becoming a substantial from MQG

×

Becoming a substantial from MQG

31 August 23

Proposed issue of securities - HCW

×

Proposed issue of securities - HCW

31 August 22

Appendix 3Y - Joseph Carrozzi

×

Appendix 3Y - Joseph Carrozzi

30 September 22

Annual Report 2022

×

Annual Report 2022

30 March 23

Healthscope Portfolio Acquisition and Equity Raising

×

Healthscope Portfolio Acquisition and Equity Raising

30 March 23

Transformational Acquisition and Equity Raising Presentation

×

Transformational Acquisition and Equity Raising Presentation

30 March 23

Cleansing Notice

×

Cleansing Notice

30 March 23

Proposed issue of securities - HCW

×

Proposed issue of securities - HCW

30 March 23

Dividend/Distribution - HCW

×

Dividend/Distribution - HCW

30 June 22

Change in substantial holding from MQG

×

Change in substantial holding from MQG

30 August 23

Application for quotation of securities - HCW

×

Application for quotation of securities - HCW

29 November 23

Application for quotation of securities - HCW

×

Application for quotation of securities - HCW

29 March 23

Pause in Trading

×

Pause in Trading

29 March 23

Trading Halt

×

Trading Halt

28 August 23

Fund Payment Notice

×

Fund Payment Notice

28 April 23

Western Sydney Asset Tour Presentation

×

Western Sydney Asset Tour Presentation

28 April 23

Application for quotation of securities - HCW

×

Application for quotation of securities - HCW

27 September 23

Annual Report 2023

×

Annual Report 2023

27 November 23

Fund Payment Notice

×

Fund Payment Notice

26 April 23

Successful Completion of Underwritten Retail Offer

×

Successful Completion of Underwritten Retail Offer

26 April 23

Appendix 3Y - David Di Pilla

×

Appendix 3Y - David Di Pilla

26 April 23

Appendix 3Y - Chris Roberts

×

Appendix 3Y - Chris Roberts

25 September 23

First Close on $1.3b Healthcare and Life Sciences Fund

×

First Close on $1.3b Healthcare and Life Sciences Fund

25 November 22

Application for quotation of securities - HCW

×

Application for quotation of securities - HCW

25 January 23

Advance Notice - 2023 Half Year Financial Results

×

Advance Notice - 2023 Half Year Financial Results

25 January 23

Becoming a substantial holder from PPT

×

Becoming a substantial holder from PPT

24 July 23

Chair's Address - EGM 2023

×

Chair's Address - EGM 2023

HCW Fundamentals

Per Share Records

Historical data

Forecasted data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Per Share, Growth & Valuations
EPS (Basic) $ Lock Lock Lock Lock N/A 0.15 0.05 Lock Lock Lock
EPS (Fully Diluted) $ Lock Lock Lock Lock N/A 0.15 0.05 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A -63.7 Lock Lock Lock
     PE X Lock Lock Lock Lock N/A 33.1 21.8 Lock Lock Lock
     EV/EBITDA X Lock Lock Lock Lock N/A 31.0 37.5 Lock Lock Lock
CFPS $ Lock Lock Lock Lock N/A 0.03 -0.01 Lock Lock Lock
FCFPS $ Lock Lock Lock Lock N/A -1.48 -0.05 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A -128.1 Lock Lock Lock
     Yield % Lock Lock Lock Lock N/A -109.7 -3.8 Lock Lock Lock
DPS $ Lock Lock Lock Lock N/A 0.07 0.08 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A 2.6 Lock Lock Lock
     Yield % Lock Lock Lock Lock N/A 4.6 5.7 Lock Lock Lock
     Payout Ratio % Lock Lock Lock Lock N/A 49 139 Lock Lock Lock
BPS $ Lock Lock Lock Lock N/A 1.97 1.69 Lock Lock Lock
BPS (Tangible) $ Lock Lock Lock Lock N/A 1.97 1.69 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A -14.3 Lock Lock Lock
Shares Outstanding
Diluted m Lock Lock Lock Lock N/A 331 372 Lock Lock Lock
Basic m Lock Lock Lock Lock N/A 331 372 Lock Lock Lock

Financial Records

Historical data

Forecasted data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Income Statement
Sales $m Lock Lock Lock Lock N/A 29 49 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A 68.5 Lock Lock Lock
Selling & General Expenses $m Lock Lock Lock Lock N/A 2 2 Lock Lock Lock
Gross Income $m Lock Lock Lock Lock N/A 21 33 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A 58.2 Lock Lock Lock
     Margin % Lock Lock Lock Lock N/A 72.0 67.6 Lock Lock Lock
Cost of Goods Sold to Sales % Lock Lock Lock Lock N/A 28 32 Lock Lock Lock
EBITDA $m Lock Lock Lock Lock N/A 19 52 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A 174.6 Lock Lock Lock
     Margin % Lock Lock Lock Lock N/A 65.6 106.9 Lock Lock Lock
Depreciation & Amortisation $m Lock Lock Lock Lock N/A 0 0 Lock Lock Lock
EBIT $m Lock Lock Lock Lock N/A 19 52 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A 174.6 Lock Lock Lock
     Margin % Lock Lock Lock Lock N/A 65.6 106.9 Lock Lock Lock
Pretax Income $m Lock Lock Lock Lock N/A 50 21 Lock Lock Lock
Income Taxes $m Lock Lock Lock Lock N/A 0 0 Lock Lock Lock
Net Income $m Lock Lock Lock Lock N/A 50 20 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A -59.3 Lock Lock Lock
     Margin % Lock Lock Lock Lock N/A 170.3 41.1 Lock Lock Lock
Cash Flow Statement
Net Operating Cash Flow $m Lock Lock Lock Lock N/A 20 11 Lock Lock Lock
Capital Expenditures $m Lock Lock Lock Lock N/A 494 0 Lock Lock Lock
Net Investing Cash Flow $m Lock Lock Lock Lock N/A -522 -962 Lock Lock Lock
Net Financing Cash Flow $m Lock Lock Lock Lock N/A 505 956 Lock Lock Lock
Free Cash Flow $m Lock Lock Lock Lock N/A -474 11 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A 102.3 Lock Lock Lock
     Margin % Lock Lock Lock Lock N/A -16.3 0.2 Lock Lock Lock
Franking Balance $m Lock Lock Lock Lock N/A N/A 0 Lock Lock Lock
Balance Sheet
Cash & Short-Term Investments $m Lock Lock Lock Lock N/A 3 8 Lock Lock Lock
Total Assets $m Lock Lock Lock Lock N/A 694 1,724 Lock Lock Lock
Long Term Debt $m Lock Lock Lock Lock N/A 22 704 Lock Lock Lock
Net Debt $m Lock Lock Lock Lock N/A 20 696 Lock Lock Lock
Total Liabilities $m Lock Lock Lock Lock N/A 40 766 Lock Lock Lock
Equity $m Lock Lock Lock Lock N/A 654 951 Lock Lock Lock
Invested Capital Lock Lock Lock Lock N/A 676 1,655 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A 144.7 Lock Lock Lock
Return Ratios
Return on Assets % Lock Lock Lock Lock N/A 7.2 1.2 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock N/A 7.6 2.1 Lock Lock Lock
Return on Total Capital % Lock Lock Lock Lock N/A N/A 4.5 Lock Lock Lock
Return on Invested Capital % Lock Lock Lock Lock N/A N/A 1.7 Lock Lock Lock
Cash Flow Return on Invested Capital % Lock Lock Lock Lock N/A N/A 1.0 Lock Lock Lock

Ratios Records

Historical data

Forecasted data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Leverage
Interest Cover X Lock Lock Lock Lock N/A 5.8 4.1 Lock Lock Lock
Debt to EBITDA X Lock Lock Lock Lock N/A 1.0 13.3 Lock Lock Lock
Net Debt to Equity % Lock Lock Lock Lock N/A 3.0 73.2 Lock Lock Lock
Liquidity
Current Ratio X Lock Lock Lock Lock N/A N/A 0.0 Lock Lock Lock
Quick Ratio X Lock Lock Lock Lock N/A N/A 0.0 Lock Lock Lock
Cash & ST Inv/Current Assets % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
CFO/Current Liabilities % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
Balance Sheet Efficiency
Receivables Turnover X Lock Lock Lock Lock N/A N/A 12.0 Lock Lock Lock
Inventory Turnover X Lock Lock Lock Lock N/A N/A 0.0 Lock Lock Lock
Working Capital Turnover X Lock Lock Lock Lock N/A N/A 0.0 Lock Lock Lock
Payables Turnover X Lock Lock Lock Lock N/A N/A 0.0 Lock Lock Lock
Asset Turnover X Lock Lock Lock Lock N/A 0.0 0.0 Lock Lock Lock
Du Pont
Asset Turnover X Lock Lock Lock Lock N/A 0.0 0.0 Lock Lock Lock
x Pretax Margin % Lock Lock Lock Lock N/A 170.3 43.2 Lock Lock Lock
= Pretax Return on Assets % Lock Lock Lock Lock N/A 7.2 1.2 Lock Lock Lock
x Tax Rate Complement (1-Tax Rate) % Lock Lock Lock Lock N/A 0.0 0.0 Lock Lock Lock
Return on Assets % Lock Lock Lock Lock N/A 7.2 1.2 Lock Lock Lock
x Equity Multiplier (Assets/Equity) % Lock Lock Lock Lock N/A 1.1 1.8 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock N/A 7.6 2.1 Lock Lock Lock
x Earnings Retention (1-Payout) % Lock Lock Lock Lock N/A 50.8 -38.9 Lock Lock Lock
= Reinvestment Rate (%) % Lock Lock Lock Lock N/A 3.9 -0.8 Lock Lock Lock
Operating Cycle
Days of Inventory on Hand Days Lock Lock Lock Lock N/A N/A 0.0 Lock Lock Lock
+ Days of Sales Outstanding Days Lock Lock Lock Lock N/A N/A 30.3 Lock Lock Lock
Operating Cycle Days Lock Lock Lock Lock N/A N/A 30.3 Lock Lock Lock
- Days of Payables Outstanding Days Lock Lock Lock Lock N/A N/A 0.0 Lock Lock Lock
Net Operating Cycle Days Lock Lock Lock Lock N/A N/A 30.3 Lock Lock Lock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

5.7%

Franking Level

N/A

DPSg

2.65%

Quality Yield

Lock

Falling Divs over next 2

Lock

Expected Dividend Cashflow

Dividend Clarity,
Enhanced
Strategy

Upload your portfolio and gain access to 3-year dividend forecasts for each holding with HALO Global. Empower your decision-making and maximize returns with our advanced analytical tool. Try it today.

Values and Recommendations

Key Stats

Consensus Score

Lock

Recommendation

Lock

EPS 1 month Change

Lock

Quality Yield

Lock

Falling Divs over next 2

Lock

Halo Consensus Score

Lock Chart

PEG Ratio

Lock Chart

Consensus EPS Revisions

Lock Chart

Short selling

Key Stats

Percent of Issue

3.10%

Value ($M)

25

Prior Change

-0.20%

7 Day Change

-0.10%

1 Month Change

-1.00%

3 Month Change

1.10%

Discover
Short-selling
Opportunities

Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.

HCW Shortsell

Frequently Asked Questions

The current share price of HealthCo Healthcare & Wellness REIT (HCW:ASX) is AU$1.37.
The 52-week high share price for HealthCo Healthcare & Wellness REIT (HCW:ASX) is AU$1.80.
The 52-week low share price for HealthCo Healthcare & Wellness REIT (HCW:ASX)? is AU$1.27.
The current TTM dividend payout for HealthCo Healthcare & Wellness REIT (HCW:ASX) is 5.70.
The last dividend payment of HealthCo Healthcare & Wellness REIT (HCW:ASX) is AU$0.02.
HealthCo Healthcare & Wellness REIT (HCW:ASX) has a franking level of 0%.
HealthCo Healthcare & Wellness REIT (HCW:ASX) is classified in the Real Estate.
The current P/E ratio for HealthCo Healthcare & Wellness REIT (HCW:ASX) is 21.80.
halo-logo-inverted-rgb@72ppi-1
Login
Products
Company
Important

Get the latest insights and hot tips delivered right to your inbox

Apple Store
Google Play

HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.